Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, immunoprecipitation (IP), cell culture, immunofluorescence (IF), qRT-PCR, Western blotting, and CRISPR/Cas9 gene editing. Scientific Proficiency: A proven track record of independent experimental design
-
minimum of 12 months Appointment Start Date: Early/mid 2026 Group or Departmental Website: https://evodesign.org/ (link is external) How to Submit Application Materials: Please directly contact us at
-
, including use of CRISPR, is strongly desired. In this role, you will: Plan approach to experiments in support of research projects in lab and/or field based on knowledge of scientific theory. Independently
-
Using CRISPR-Cas9 to rewire photosynthesis in plants and algae School of Biosciences PhD Research Project Self Funded Prof Matt Johnson, Dr Andy Hitchcock Application Deadline: Applications
-
fundamental and translational aspects of infectious disease (germfree/gnotobiotic animal facility, organoid cultures, T-cell engineering via CRISPR/Cas9 technology, in vivo imaging, animal models, microbiome
-
CRISPR-based gene editing in the salmon louse. The small size of its oocytes poses a challenge for the delivery of the gene editing compounds. Therefore, CRISPR is not available in this species, yet. To
-
the University of Vienna: https://doschem.univie.ac.at/ The standard employment contract is for three years . Initially limited to 1.5 years, the employment relationship is automatically extended to three years
-
these questions, we use a novel multi-omics approach that integrates high-throughput imaging and machine learning methods with CRISPR/Cas9 screens and saturation mutagenesis to answer central questions about the
-
single photon counting, nucleoproteins, CRISPR/CAS9, riboswitches, high pressure The ability to “see” single biomolecules with laser microscopy has led to a revolution in research opportunities
-
at the following website: https://biology.mit.edu/profile/h-robert-horvitz Please note: This is a fixed-term position with an anticipated end date not to exceed August 31, 2027, aligned with current HHMI funding